One Word: Validation Medical Community/Scientif
Post# of 153802
(Total Views: 684)
Posted On: 08/05/2020 2:05:22 PM
One Word: Validation
Medical Community/Scientific Community Validation
- We are < 10 days away from releasing positive mild-to-moderate results
- m2m results will then be shared with interested Big Pharma
- Dr. BP on his interview with Dr. Yo said his paper "is very close" to being published
Media Validation
- Once the m2m results are released they are going to be shared with major media
Market Validation
-We are a 2-3 weeks away from hopefully uplisting to NASDAQ and leaving the OTC and all of its pump and dump mystique behind
NP referenced "a few weeks" for potential approval of some sort. I think we were hoping that this would be a 1-2 punch with m2m and s/c data. I *assumed* the first punch was the m2m data but I am now wondering if the first punch was instead, the s/c safety peak. The second punch would then be the full m2m analysis (NP confirmed last week that the FDA hasn't even seen the m2m data yet). All that is to say, the next few weeks have so much potential.
I think the process is moving slower than I had hoped but we are checking boxes...
- EINDs validating the theory...check
- document science and get the lengthy peer-review process started...check
- getting deal with distribution partner...check
- m2m data demonstrating that we have an impact in a controlled study within 72 hours (exactly as described by Dr. Jay, Dr. Yang, Dr. Patterson, the testimonials, etc.)...check
- leronlimab appears safer in m2m patients than sugar water...check
- leronlimab is safe in s/c patients...check
If we can parlay this to the validation listed above this story will have a beautiful ending.
Anyhow, just wanted to share as I sometimes read these stories/articles and get frustrated along with all of you. I just needed to take a step back and look at our current situation from afar. Call me crazy, but things still look really good. GLTA
Medical Community/Scientific Community Validation
- We are < 10 days away from releasing positive mild-to-moderate results
- m2m results will then be shared with interested Big Pharma
- Dr. BP on his interview with Dr. Yo said his paper "is very close" to being published
Media Validation
- Once the m2m results are released they are going to be shared with major media
Market Validation
-We are a 2-3 weeks away from hopefully uplisting to NASDAQ and leaving the OTC and all of its pump and dump mystique behind
NP referenced "a few weeks" for potential approval of some sort. I think we were hoping that this would be a 1-2 punch with m2m and s/c data. I *assumed* the first punch was the m2m data but I am now wondering if the first punch was instead, the s/c safety peak. The second punch would then be the full m2m analysis (NP confirmed last week that the FDA hasn't even seen the m2m data yet). All that is to say, the next few weeks have so much potential.
I think the process is moving slower than I had hoped but we are checking boxes...
- EINDs validating the theory...check
- document science and get the lengthy peer-review process started...check
- getting deal with distribution partner...check
- m2m data demonstrating that we have an impact in a controlled study within 72 hours (exactly as described by Dr. Jay, Dr. Yang, Dr. Patterson, the testimonials, etc.)...check
- leronlimab appears safer in m2m patients than sugar water...check
- leronlimab is safe in s/c patients...check
If we can parlay this to the validation listed above this story will have a beautiful ending.
Anyhow, just wanted to share as I sometimes read these stories/articles and get frustrated along with all of you. I just needed to take a step back and look at our current situation from afar. Call me crazy, but things still look really good. GLTA
(15)
(0)